Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.59T
Total marketcap
$263.86B
Total volume
BTC 60.45%     ETH 7.29%
Dominance

Morphic Holding MORF Stock

56.99 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
2.86B USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Morphic Holding Price Chart

Morphic Holding MORF Financial and Trading Overview

Morphic Holding stock price 56.99 USD
Previous Close 59.82 USD
Open 59.62 USD
Bid 0 USD x 800
Ask 0 USD x 800
Day's Range 58.77 - 59.93 USD
52 Week Range 20.41 - 63.08 USD
Volume 377.81K USD
Avg. Volume 587.42K USD
Market Cap 2.72B USD
Beta (5Y Monthly) 1.145448
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 73.88 USD

MORF Valuation Measures

Enterprise Value 1.94B USD
Trailing P/E N/A
Forward P/E -14.8325
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 39.433407
Price/Book (mrq) 5.5144534
Enterprise Value/Revenue 28.096
Enterprise Value/EBITDA -27.701

Trading Information

Morphic Holding Stock Price History

Beta (5Y Monthly) 1.145448
52-Week Change 170.78%
S&P500 52-Week Change 20.43%
52 Week High 63.08 USD
52 Week Low 20.41 USD
50-Day Moving Average 51.62 USD
200-Day Moving Average 36.54 USD

MORF Share Statistics

Avg. Volume (3 month) 587.42K USD
Avg. Daily Volume (10-Days) 486.38K USD
Shares Outstanding 45.83M
Float 28.74M
Short Ratio 4.07
% Held by Insiders 18.88%
% Held by Institutions 84.62%
Shares Short 2.35M
Short % of Float 7.71%
Short % of Shares Outstanding 5.12%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -92.37%
Operating Margin (ttm) -102.87%
Gross Margin -53.81%
EBITDA Margin -101.42%

Management Effectiveness

Return on Assets (ttm) -10.56%
Return on Equity (ttm) -17.21%

Income Statement

Revenue (ttm) 68.95M USD
Revenue Per Share (ttm) 1.77 USD
Quarterly Revenue Growth (yoy) -78.10%
Gross Profit (ttm) -31254000 USD
EBITDA -69930000 USD
Net Income Avi to Common (ttm) -63692000 USD
Diluted EPS (ttm) -1.58
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 421.28M USD
Total Cash Per Share (mrq) 10.61 USD
Total Debt (mrq) 3.48M USD
Total Debt/Equity (mrq) 0.82 USD
Current Ratio (mrq) 32.323
Book Value Per Share (mrq) 10.759

Cash Flow Statement

Operating Cash Flow (ttm) -104283000 USD
Levered Free Cash Flow (ttm) -48465624 USD

Profile of Morphic Holding

Country United States
State MA
City Waltham
Address 35 Gatehouse Drive, A2
ZIP 02451
Phone 781 996 0955
Website https://www.morphictx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 107

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Q&A For Morphic Holding Stock

What is a current MORF stock price?

Morphic Holding MORF stock price today per share is 56.99 USD.

How to purchase Morphic Holding stock?

You can buy MORF shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Morphic Holding?

The stock symbol or ticker of Morphic Holding is MORF.

Which industry does the Morphic Holding company belong to?

The Morphic Holding industry is Biotechnology.

How many shares does Morphic Holding have in circulation?

The max supply of Morphic Holding shares is 50.22M.

What is Morphic Holding Price to Earnings Ratio (PE Ratio)?

Morphic Holding PE Ratio is 0.00000000 now.

What was Morphic Holding earnings per share over the trailing 12 months (TTM)?

Morphic Holding EPS is 0 USD over the trailing 12 months.

Which sector does the Morphic Holding company belong to?

The Morphic Holding sector is Healthcare.

Morphic Holding MORF included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 15455.34 USD
-0.85
4.92B USD 14784.03 USD 16292.28 USD 4.92B USD
NASDAQ Global Market Composite NQGM 1621.83 USD
-1.58
1547.55 USD 1705.12 USD
Stlmt ID NASDAQ Biotechnology NBX 4153.28 USD
+1.21
4281.91 USD 4648.11 USD
Nasdaq US 700 Small Cap Index NQUS700SC 1910.76 USD
-1.45
1835.13 USD 2001.25 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2482.07 USD
-0.74
2369.22 USD 2594.76 USD
NASDAQ Biotechnology NBI 3808.02 USD
-2.46
3700.88 USD 3966.57 USD
NASDAQ HealthCare IXHC 854.98 USD
-1.7
828.4 USD 890 USD